Macquarie Group’s Rocket Pharmaceuticals RCKT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$142K	Hold	58,000	–	–	﹤0.01%	1559
2025 Q1	$387K	Hold	58,000	–	–	﹤0.01%	1504
2024 Q4	$729K	Hold	58,000	–	–	﹤0.01%	1395
2024 Q3	$1.07M	Hold	58,000	–	–	﹤0.01%	1364
2024 Q2	$1.25M	Hold	58,000	–	–	﹤0.01%	1335
2024 Q1	$1.56M	Hold	58,000	–	–	﹤0.01%	1292
2023 Q4	$1.74M	Hold	58,000	–	–	﹤0.01%	1263
2023 Q3	$1.19M	Hold	58,000	–	–	﹤0.01%	1306
2023 Q2	$1.15M	Hold	58,000	–	–	﹤0.01%	1331
2023 Q1	$994K	Hold	58,000	–	–	﹤0.01%	1359
2022 Q4	$1.14M	Sell	58,000 -317	-0.5%	-$6.2K	﹤0.01%	1375
2022 Q3	$940K	Sell	58,317 -581	-1%	-$9.37K	﹤0.01%	1428
2022 Q2	$810K	Hold	58,898	–	–	﹤0.01%	1529
2022 Q1	$934	Hold	58,898	–	–	﹤0.01%	1557
2021 Q4	$1.29M	Hold	58,898	–	–	﹤0.01%	1504
2021 Q3	$1.76M	Hold	58,898	–	–	﹤0.01%	1416
2021 Q2	$2.61M	Hold	58,898	–	–	﹤0.01%	1334
2021 Q1	$2.61M	Sell	58,898 -276	-0.5%	-$12.2K	﹤0.01%	1099
2020 Q4	$3.25M	Hold	59,174	–	–	﹤0.01%	971
2020 Q3	$1.35M	Hold	59,174	–	–	﹤0.01%	1163
2020 Q2	$1.24M	Buy	59,174 +1,174	+2%	+$24.6K	﹤0.01%	1144
2020 Q1	$809K	Hold	58,000	–	–	﹤0.01%	1152
2019 Q4	$1.32M	Hold	58,000	–	–	﹤0.01%	1166
2019 Q3	$676K	Hold	58,000	–	–	﹤0.01%	1316
2019 Q2	$870K	Buy	58,000 +3,000	+5%	+$45K	﹤0.01%	1251
2019 Q1	$965K	Buy	55,000 +35,000	+175%	+$614K	﹤0.01%	1195
2018 Q4	$296K	Buy	+20,000	New	+$296K	﹤0.01%	1367